Sionna Therapeutics (NASDAQ:SION) is now covered by analysts at Lifesci Capital. They set an "outperform" rating and a $60.00 price target on the stock.
Sionna Therapeutics (NASDAQ:SION) was upgraded by analysts at
Wall Stree
Sionna Therapeutics Valuation Topping $2 Billion Is 'Too Optimistic', RBC Says [Yahoo! Finance]
Sionna Therapeutics (NASDAQ:SION) had its "underperform" rating reaffirmed by analysts at Royal Bank Of Canada. They now have a $24.00 price target on the stock.
Sionna Therapeutics to Participate in Upcoming December Investor Conferences